Clinical Trial Update: A Study of Eltrombopag in Patients With CMML and Thrombocytopenia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating eltrombopag in CMML patients with thrombocytopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelomonocytic Leukemia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Groupe Francophone des Myelodysplasies | Conditions: CMML, Thrombocytopenia | Phase 1, Phase 2 | Status: COMPLETED